Skip to main content

Table 2 Susceptibility of MRSA isolates to vancomycin and teicoplanin

From: Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004

    Vancomycin MIC (%) Teicoplanin MIC (%)
S/N Year # ≤ 2 mg/L 3 mg/L 4 mg/L ≤ 2 mg/L 3 mg/L 4 mg/L
1 1999 336 199(59.2) 120(35.7) 17(5.1) 225(70.0) 99(29.5) 12(3.5)
2 2000 542 494(91.1) 47(8.7) 1(0.2) 479(88.4) 58(10.7) 5(0.9)
3 2001 533 385(72.2) 133(25.0) 15(2.8) 293(55.0) 160(30.0) 80(15.0)
4 2002 884 773(87.4) 107(12.1) 4(0.5) 740(83.7) 112(12.7) 32(3.6)
5 2003 785 653(83.2) 132(16.8) 0.00 623(79.4) 162(20.6) 0.00
6 2004 930 807(86.8) 121(13.0) 2(0.2) 740(79.6) 176(18.9) 14(1.5)
Total 4010 3311(82.5) 660(16.5) 39 (1.0) 3100 (77.3) 767(19.1) 143(3.6)